Skip to main content
. 2017 Jul 15;8(5):768–777. doi: 10.1002/jcsm.12209

Table 4.

Univariable and multivariable analysis for prognostic factors of overall survival

Factors Univariable Multivariable
Hazard ratio (95%CI) P‐value Hazard ratio (95%CI) P‐value
Age ≥ 65 years 1.33 (0.72–2.45) 0.360
Lung cancera 5.03 (2.61–9.67) <0.001 6.06 (2.45–15.04) <0.001
Tumour stageb
 I 0.00 (0.00‐NE) 0.255
 III 4.65 (1.05–20.62) 0.043
 IV 5.31 (1.23–22.9) 0.025
ECOGc
 1 3.39 (1.68–6.81) <0.001 1.48 (0.54–4.08) 0.450
 2 8.30 (3.15–21.91) <0.001 5.87 (1.78–19.41) 0.004
 3 13.12 (4.21–40.84) <0.001 3.37 (0.57–19.91) 0.180
SNAQ score 0.82 (0.74–0.91) <0.001
Cachexia 1.81 (0.88–3.74) 0.108
Low muscularity 1.96 (1.04–3.68) 0.036 3.63 (1.58–8.30) 0.002
SMD < 30 HU 2.01 (1.06–3.81) 0.032
Activin A ≥ 408 pg/mL 4.24 (1.89–9.53) <0.001 4.07 (1.44–11.52) 0.008
Myostatin < 1599 pg/mL 2.16 (1.18–3.96) 0.013
LDH ≥ 250 UI/L 1.15 (0.56–2.35) 0.699
CRP (mg/dL) 1.06 (1.02–1.11) 0.008
Albumin < 3.5 g/dL 4.50 (2.15–9.41) <0.001 2.93 (1.17–7.34) 0.022
a

Reference was colorectal cancer.

b

Reference was tumour stage II.

c

Reference was ECOG 0.

SMD, skeletal muscle density; LDH, lactate deshydrogenase; CRP, C‐reactive protein; SNAQ, Simplified Nutritional Appetite Questionnaire.